{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T16:15:58Z","timestamp":1788797758137,"version":"build-2803163510"},"reference-count":44,"publisher":"Tech Science Press","issue":"4","license":[{"start":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T00:00:00Z","timestamp":1710806400000},"content-version":"vor","delay-in-days":78,"URL":"https:\/\/doi.org\/10.32604\/TSP-CROSSMARKPOLICY"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OR"],"published-print":{"date-parts":[[2024]]},"DOI":"10.32604\/or.2024.047021","type":"journal-article","created":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T07:36:45Z","timestamp":1707205005000},"page":"785-797","update-policy":"https:\/\/doi.org\/10.32604\/tsp-crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["The role of polymorphic cytochrome P450 gene (CYP2B6) in B-chronic lymphocytic leukemia (B-CLL) incidence and outcome among Egyptian patients"],"prefix":"10.32604","volume":"32","author":[{"given":"MENNA","family":"AL-ADL","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MAGDY M.","family":"YOUSSEF","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AHMED","family":"EL-SEBAIE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SHERIF","family":"REFAAT","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AFAF","family":"EL-SAID","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"17807","published-online":{"date-parts":[[2024]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.3390\/ijms21051825","article-title":"Immune response dysfunction in chronic lymphocytic leukemia: Dissecting molecular mechanisms and microenvironmental conditions","volume":"21","author":"Arruga","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"840616","DOI":"10.3389\/fonc.2022.840616","article-title":"Trends in disease burden of chronic lymphocytic leukemia at the global, regional, and national levels from 1990 to 2019, and projections until 2030: A population-based epidemiologic study","volume":"12","author":"Ou","year":"2022","journal-title":"Frontiers in Oncology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1002\/ajh.26367","article-title":"Chronic lymphocytic leukemia: 2022 update on diagnostic and therapeutic procedures","volume":"96","author":"Hallek","year":"2021","journal-title":"American Journal of Hematology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/mas.21570","article-title":"DNA adducts: Formation, biological effects, and new biospecimens for mass spectrometric measurements in humans","volume":"39","author":"Hwa Yun","year":"2020","journal-title":"Mass Spectrometry Reviews"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"9834","DOI":"10.1038\/s41598-021-88700-y","article-title":"The cytochrome P450 (CYP) superfamily in cnidarians","volume":"11","author":"Pankov","year":"2021","journal-title":"Scientific Reports"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"671640","DOI":"10.3389\/fphar.2021.671640","article-title":"Cellular mechanisms of liver fibrosis","volume":"12","author":"Acharya","year":"2021","journal-title":"Frontiers in Pharmacology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/03602532.2020.1858856","article-title":"Cytochrome P450 expression and regulation in the brain","volume":"53","author":"Kuban","year":"2021","journal-title":"Drug Metabolism Reviews"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"108013","DOI":"10.1016\/j.dib.2022.108013","volume":"41","author":"Olack","year":"2022","journal-title":"Data in Brief"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"692234","DOI":"10.3389\/fgene.2021.692234","volume":"12","author":"Langmia","year":"2021","journal-title":"Frontiers in Genetics"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"11770","DOI":"10.1038\/s41598-023-38983-0","article-title":"Association between CYP2B6 genetic variability and cyclophosphamide therapy in pediatric patients with neuroblastoma","volume":"13","author":"Mang\u00f3","year":"2023","journal-title":"Scientific Reports"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2147\/PGPM.S345038","volume":"15","author":"Bunu","year":"2022","journal-title":"Pharmacogenomics and Personalized Medicine"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"e26614","DOI":"10.1097\/MD.0000000000026614","volume":"100","author":"Kassogue","year":"2021","journal-title":"Medicine"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"491895","DOI":"10.3389\/fgene.2020.491895","article-title":"How can drug metabolism and transporter genetics inform psychotropic prescribing?","volume":"11","author":"Carvalho Henriques","year":"2020","journal-title":"Frontiers in Genetics"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1038\/s41598-022-07022-9","volume":"12","author":"Mang\u00f3","year":"2022","journal-title":"Scientific Reports"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/ijc.28356","volume":"134","author":"Justenhoven","year":"2014","journal-title":"International Journal of Cancer"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00277-010-1085-z","volume":"90","author":"Yuan","year":"2011","journal-title":"Annals of Hematology"},{"key":"ref17","first-page":"185","article-title":"Chronic lymphocytic leukemia\/small lymphocytic lymphoma, version 4.2020, NCCN clinical practice guidelines in oncology","volume":"18","author":"Wierda","year":"2020","journal-title":"Journal of the National Comprehensive Cancer Network"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1182\/blood-2017-09-806398","article-title":"iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL","volume":"131","author":"Hallek","year":"2018","journal-title":"Blood"},{"key":"ref19","first-page":"2391","article-title":"Pharmacogenetics of efavirenz and central nervous system side effects: An adult AIDS clinical trials group study","volume":"18","author":"Haas","year":"2004","journal-title":"AIDS"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1590\/0001-3765201720160355","volume":"89","author":"M\u00fcller","year":"2017","journal-title":"Anais da Academia Brasileira de Ciencias"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/s41375-017-0007-7","article-title":"ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-update on methodological approaches and results interpretation","volume":"32","author":"Malcikova","year":"2018","journal-title":"Leukemia"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s43042-021-00145-0","article-title":"Impact of Cytochromes P450 3A4 and 2B6 gene polymorphisms on predisposition and prognosis of acute myeloid leukemia: An Egyptian case-control study. Egypt Journal Medical","volume":"22","author":"Botros","year":"2021","journal-title":"Egyptian Journal of Medical Human Genetics"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1182\/blood.V46.2.219.219","article-title":"Clinical staging of chronic lymphocytic leukemia","volume":"46","author":"Rai","year":"1975","journal-title":"Blood"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V","article-title":"A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis","volume":"48","author":"Binet","year":"1981","journal-title":"Cancer"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.annonc.2020.09.019","article-title":"Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"32","author":"Eichhorst","year":"2021","journal-title":"Annals of Oncology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.2023.1946","article-title":"Diagnosis and treatment of chronic lymphocytic leukemia: A review","volume":"329","author":"Shadman","year":"2023","journal-title":"JAMA"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3960\/jslrt.20036","article-title":"Pathogenesis of chronic lymphocytic leukemia and the development of novel therapeutic strategies","volume":"60","author":"Kikushige","year":"2020","journal-title":"Journal of Clinical and Experimental Hematopathology"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1002\/ajh.25595","article-title":"Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment","volume":"94","author":"Hallek","year":"2019","journal-title":"American Journal of Hematology"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.mpaic.2020.07.001","article-title":"Drugs and the liver","volume":"21","author":"Vaja","year":"2020","journal-title":"Anaesthesia and Intensive Care Medicine"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the world health organization classification of haematolymphoid tumours: Lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3389\/fimmu.2018.00683","article-title":"Chronic lymphocytic leukemia B-cell normal cellular counterpart: Clues from a functional perspective","volume":"9","author":"Darwiche","year":"2018","journal-title":"Frontiers in Immunology"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/ejh.13833","article-title":"Implementation of international prognostic index with flow cytometry immunophenotyping for better risk stratification of chronic lymphocytic leukemia","volume":"109","author":"Giudice","year":"2022","journal-title":"European Journal of Haematology"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"964","DOI":"10.3390\/diagnostics13050964","article-title":"Perspectives on the application of cytogenomic approaches in chronic lymphocytic leukaemia","volume":"13","author":"Wan Mohamad Zamri","year":"2023","journal-title":"Diagnostics"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.clml.2019.03.002","article-title":"Prognostic and predictive effect of IGHV mutational status and load in chronic lymphocytic leukemia: Focus on FCR and BR treatments","volume":"19","author":"Visentin","year":"2019","journal-title":"Clinical Lymphoma, Myeloma Leukemia"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"896","DOI":"10.3390\/cancers11070896","article-title":"Elevated lactate dehydrogenase has prognostic relevance in treatment-na\u00efve patients affected by chronic lymphocytic leukemia with trisomy 12","volume":"11","author":"Autore","year":"2019","journal-title":"Cancers"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"e88879","DOI":"10.1371\/journal.pone.0088879","volume":"9","author":"Daraki","year":"2014","journal-title":"PLoS One"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.leukres.2008.11.014","volume":"33","author":"Berk\u00f6z","year":"2009","journal-title":"Leukemia Research"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/hon.3145","article-title":"First line therapy of CLL","volume":"41","author":"Hallek","year":"2023","journal-title":"Hematological Oncology"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/cpt.2166","volume":"110","author":"Desta","year":"2021","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.bbmt.2017.10.035","article-title":"Cellular immunotherapy for hematologic malignancies: Beyond bone marrow transplantation","volume":"24","author":"Cirillo","year":"2018","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.3390\/cancers13102468","article-title":"Current treatment options in CLL","volume":"13","author":"Bewarder","year":"2021","journal-title":"Cancers"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.3390\/cells12151965","article-title":"Anti-cancer prodrug cyclophosphamide exerts thrombogenic effects on human venous endothelial cells independent of CYP450 activation-relevance to thrombosis","volume":"12","author":"Kr\u00fcger-Genge","year":"2023","journal-title":"Cells"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/jcph.878","article-title":"Cytochrome P450 genetic variations can predict mRNA expression, cyclophosphamide 4-hydroxylation, and treatment outcomes in Chinese patients with non-Hodgkin\u2019s lymphoma","volume":"57","author":"Shu","year":"2017","journal-title":"Journal of Clinical Pharmacology"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1182\/blood-2013-07-516666","volume":"122","author":"Johnson","year":"2013","journal-title":"Blood"}],"container-title":["Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.techscience.com\/files\/or\/2024\/TSP_OR-32-4\/OncolRes-32-04-47021\/OncolRes-32-47021.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T06:36:57Z","timestamp":1741243017000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.techscience.com\/or\/v32n4\/55767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":44,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024]]},"published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.32604\/or.2024.047021","relation":{},"ISSN":["1555-3906"],"issn-type":[{"value":"1555-3906","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"2023-10-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-17","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-20","order":2,"name":"published","label":"Published Online","group":{"name":"publication_history","label":"Publication History"}}]}}